Company · CIK 0001764013
Immunovant, Inc.
IMVTSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$28.69+$1.06 (+3.86%)
IMVT · Last trade
- Prev close
- $27.62
- Range (29d)
- $26.73 – $37.29
On the record
Recent filings
- 8-KIMVTCurrent report0001764013-26-000106 · 154.1 KBSEC(opens sec.gov)
- SCHEDULE 13G/AIMVTImmunovant, Inc.0001172661-26-003481 · 11.5 KBSEC(opens sec.gov)
- 10-QIMVTQuarterly update0001764013-26-000101 · 4.4 MBSEC(opens sec.gov)
- 8-KIMVTCurrent report0001764013-26-000100 · 249.0 KBSEC(opens sec.gov)
- 10-KIMVTAnnual report0001764013-26-000064 · 11.9 MBSEC(opens sec.gov)
- 8-KIMVTCurrent report0001764013-26-000062 · 307.1 KBSEC(opens sec.gov)
- 10-QIMVTQuarterly update0001764013-26-000011 · 5.6 MBSEC(opens sec.gov)
- 8-KIMVTCurrent report0001764013-26-000010 · 293.7 KBSEC(opens sec.gov)
- 8-KIMVTCurrent report0001193125-25-317577 · 421.5 KBSEC(opens sec.gov)
- 8-KIMVTCurrent report0001193125-25-314994 · 165.3 KBSEC(opens sec.gov)
Insiders
- Barnett Eva ReneeChief Financial Officer
- Bauer JakeDirector
- Butchko Julia G.Chief Development Officer
- Connealy Pamela AnnChief Financial Officer
- Elliott Michael JamesChief Scientific Officer
- Fromkin Andrew J.Director
- Geffner MichaelChief Medical Officer
- Girao TiagoChief Financial Officer
- Gloria MelanieChief Operating Officer
- GRANADILLO PEDRO PDirector
Tickers
Addresses
business
1000 PARK FORTY PLAZA
DURHAM, NC, 27713
mailing
1000 PARK FORTY PLAZA
DURHAM, NC, 27713
Former names
- Health Sciences Acquisitions Corp2019-12-20
Same industry
Related Biological Products, (No Diagnostic Substances) companies
- TBIO-TECHNE CorpTECH
- AAERIE PHARMACEUTICALS INC
- CCellular Biomedicine Group, Inc.
- TTourmaline Bio, Inc.TRML
- NNKGen Biotech, Inc.
- TTevogen Inc.TVGN
- AAttovia Therapeutics, Inc.ATTO
View all Biological Products, (No Diagnostic Substances) companies